Patients with primary immunodeficiencies in pediatric intensive care unit: outcomes and mortality-related risk...

Area of Science:

• Pediatric critical care medicine
• Immunology
• Clinical outcomes research

Background:

• Primary immunodeficiency (PID) encompasses a heterogeneous group of genetic disorders affecting the immune system.
• Patients with PID are susceptible to severe infections and may require intensive care.
• Understanding the outcomes and risk factors for PID patients in the pediatric intensive care unit (PICU) is crucial for improving management.

Purpose of the Study:

• To determine the frequency, characteristics, and clinical course of PID patients admitted to the PICU.
• To identify factors associated with mortality in this patient population.
• To provide insights for predicting poor outcomes and guiding intensive care.

Main Methods:

• A retrospective review of pediatric patients (1 month to 18 years) with PID admitted to a tertiary teaching children's hospital's PICU between January 2002 and January 2012.
• Data collected included diagnoses, reasons for admission, treatments received (e.g., hematopoietic stem cell transplantation), and outcomes.

Main Results:

• A total of 51 patients accounted for 71 PICU admissions; severe combined immunodeficiency was the most common diagnosis.
• Respiratory problems were the leading cause for admission.
• Overall survival was 56% across all admission episodes. Significant risk factors for mortality included mechanical ventilation, multiple organ system failure, renal replacement therapy, inotrope use, higher PELOD scores, and longer PICU stays.

Conclusions:

• This study provides the first comprehensive analysis of outcomes and mortality risk factors for PID patients in the PICU.
• Effective PICU management is as vital as early diagnosis and treatment for PID patients.
• Identifying patients at high risk for adverse outcomes can aid in optimizing intensive care strategies and improving survival rates.